Increased serum fibroblast growth factor 21 levels in patients with schizophrenia.
Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, PR China.
Ying
Y
Qing
Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, PR China School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, PR China.
Jinglei
J
Yang
Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, PR China clwan@sjtu.edu.cn.
Chunling
C
Wan
D000328:Adult; D016022:Case-Control Studies; D002952:Citric Acid Cycle; D005260:Female; D005346:Fibroblast Growth Factors / Q000097:blood*; D006801:Humans; D007656:Ketoglutaric Acids / Q000097:blood; D019344:Lactic Acid / Q000097:blood; D008293:Malates / Q000097:blood; D008297:Male; D008875:Middle Aged; D019289:Pyruvic Acid / Q000097:blood; D012559:Schizophrenia / Q000097:blood*; D055815:Young Adult
D007656:Ketoglutaric Acids; D008293:Malates; C414620:fibroblast growth factor 21; D019344:Lactic Acid; D005346:Fibroblast Growth Factors; C030298:malic acid; D019289:Pyruvic Acid